Free Thyroxine Measured by Equilibrium Dialysis and Nine Immunoassays in Sera with Various Serum Thy - roxine - binding

References 1. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs. In: Hardmam JG, Limbird LE, Gilman AG, eds. The pharmacological basis of therapeutics, 10th ed. New York: McGraw-Hill, 1996:1649–78. 2. Greenstein S, Ghias K, Krett NL, Rosen ST. Mechanisms of glucocorticoidmediated apoptosis in hematological malignancies. Clin Cancer Res 2002; 8:1681–94. 3. Arai K, Chrousos GP. Hormone-nuclear receptor interactions in health and disease. Glucocorticoid resistance. Baillieres Clin Endocrinol Metab 1994; 8:317–31. 4. Panarelli M, Fraser R. The glucocorticoid receptor and hypertension. Endocr Res 1994;20:101–16. 5. DeRijk RH, Schaaf M, de Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 2002;81:103–22. 6. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2000;8:211–8. 7. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144–51. 8. Schaaf MJ, Cidlowski JA. AUUUA motifs in the 3 UTR of human glucocorticoid receptor and mRNA destabilize mRNA and decrease receptor protein expression. Steroids 2002;67:627–36. 9. Murray JC, Smith RF, Ardinger HA, Weinberger C. RFLP for the glucocorticoid receptor (GRL) located at 5q11–5q13. Nucleic Acids Res 1987;15:6765. 10. Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, et al. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 1998;83:1846–52. 11. Ukkola O, Perusse L, Chagnon YC, Despres JP, Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord 2001;25:1332–9. 12. Buemann B, Vohl MC, Chagnon M, Chagnon YC, Gagnon J, Perusse L, et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 1997; 5:186–92. 13. Weaver JU, Hitman GA, Kopelman PG. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol 1992;9: 295–300. 14. Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis 2001;157:221–4. 15. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473–82. 16. Grenett HE, Khan N, Jiang W, Booyse FM. Identification of the Hind III polymorphic site in the PAI-1 gene: analysis of the PAI-1 Hind III polymorphism by PCR. Genet Test 2000;4:65–8. 17. Metes D, Gambotto AA, Nellis J, Ruscin A, Stewart-Akers AM, Morel PA, et al. Identification of the CD32/FcgammaRIIc-Q13/STP13 polymorphism using an allele-specific restriction enzyme digestion assay. J Immunol Methods 2001;258:85–95. 18. Gold B. Origin and utility of the reverse dot-blot. Expert Rev Mol Diagn 2003;3:143–52. 19. Labuda D, Krajinovic M, Richer C, Skoll A, Sinnett H, Yotova V, et al. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Anal Biochem 1999;275:84–92.